It was announced March 7, 2011 that CaridianBCT, a Lakewood, Colorado-based medical technology company is being acquired by Tokyo-based Terumo Corp., for a price of $2.63 billion. CaridianBCT, with operations in over 30 countries and sales in more than 96 countries throughout the world, manufactures automated blood component processing technology and medical specialty products.
The company was founded by two individuals in 1964 as Cobe Laboratories.
It was acquired by Gambro AB, a publicly traded multinational health care
company based in Sweden, in 1990. In 2008, the company was purchased by
Indap, a private equity firm.
CaridianBCT, combined with Terumo Corp., will continue to be based in
Lakewood, which will remain the hub of the company’s R&D and
manufacturing operations. It employs about 1,600 in Lakewood and more
than 2300 worldwide.
The company, under the leadership of David Perez, president and CEO and
member of the board of directors of CaridianBCT, is known as a very progressive
and dynamic organization. Perez said it is unlikely that there will be
job cuts in Lakewood.
The acquisition is expected to be completed in late April to early May, 2011.